Indaptus Therapeutics Inc (INDP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $422.38M
Last updated: Nov 17, 2026 at 11:04 AM ET
Indaptus Therapeutics Inc (INDP) Competitors
The companies most similar to Indaptus Therapeutics are Avalo Therapeutics (AVTX), Candel Therapeutics (CADL) and Century Therapeutics (IPSC). By market cap, Indaptus Therapeutics ranks 8th of the 13 companies on this page; OmniAb (OABI) is the largest at $716.17M.
Peer Comparison
INDP's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Indaptus Therapeutics (INDP) | $422.38M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Avalo Therapeutics Inc (AVTX) | $448.71M | N/A | N/A | 0.0% | N/A | -69.3% | 0.00% |
| Candel Therapeutics Inc (CADL) | $486.37M | N/A | N/A | 0.0% | -43.5% | 0.0% | 0.00% |
| Century Therapeutics Inc (IPSC) | $299.63M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Surrozen Inc (SRZN) | $602.54M | N/A | 36.1x | 0.0% | N/A | 408.6% | 0.00% |
| Kyverna Therapeutics, Inc. Common Stock (KYTX) | $319.27M | N/A | N/A | 0.0% | -81.5% | 0.0% | 0.00% |
| Immuneering Corp (IMRX) | $240.27M | N/A | N/A | 0.0% | N/A | -99.8% | 0.00% |
| Immix Biopharma Inc (IMMX) | $657.09M | N/A | N/A | 0.0% | -14.9% | 0.0% | 0.00% |
| Prelude Therapeutics Inc (PRLD) | $275.32M | N/A | 16.3x | -269.7% | N/A | 41.0% | 0.00% |
| OmniAb Inc. (OABI) | $716.17M | N/A | 15.7x | -108.1% | -17.5% | 78.3% | 0.00% |
| Tectonic Therapeutic, Inc. (TECX) | $413.27M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Shattuck Labs Inc (STTK) | $473.57M | N/A | N/A | 0.0% | N/A | -66.6% | 0.00% |
| Gyre Therapeutics Inc. (GYRE) | $471.74M | N/A | 3.8x | -22.7% | N/A | 0.7% | 0.00% |
| Peer median | $460.22M | N/A | 16.0x | 0.0% | -30.5% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Indaptus Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Avalo Therapeutics Inc (AVTX) | Avalo Therapeutics Inc is a forward-thinking clinical-stage biotechnology company focused on developing transformative therapies for rare and underserved... | AVTX competitors |
| Candel Therapeutics Inc (CADL) | Candel Therapeutics Inc. is a pioneering biotechnology company focused on revolutionizing cancer treatment through its proprietary oncolytic virus platform... | CADL competitors |
| Century Therapeutics Inc (IPSC) | Century Therapeutics Inc. (Ticker: IPSC) is a leading biotechnology company specializing in allogenic cell therapy... | IPSC competitors |
| Surrozen Inc (SRZN) | Surrozen Inc. is a clinical-stage biopharmaceutical company at the forefront of developing innovative therapeutics using its proprietary SIRPa-IgG platform... | SRZN competitors |
| Kyverna Therapeutics, Inc. Common Stock (KYTX) | Kyverna Therapeutics, Inc. is an innovative biotechnology company focused on advancing immunotherapies for autoimmune diseases and other significant health... | KYTX competitors |
| Immuneering Corp (IMRX) | Immuneering Corp (IMRX) is a cutting-edge biotechnology firm dedicated to advancing targeted therapeutics for cancer and other critical illnesses through its... | IMRX competitors |
| Immix Biopharma Inc (IMMX) | Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of various tissue-specific therapies in oncology... | IMMX competitors |
| Prelude Therapeutics Inc (PRLD) | Prelude Therapeutics Incorporated, a precision clinical-stage oncology company, focuses on the discovery and development of small molecule therapies optimized... | PRLD competitors |
| OmniAb Inc. (OABI) | OmniAb Inc. is an innovative biotechnology company dedicated to the development of fully human therapeutic antibodies via its advanced OmniAb platform. | OABI competitors |
| Tectonic Therapeutic, Inc. (TECX) | Tectonic Therapeutic, Inc. engages in the discovery of antibodies and other biologic drugs targeting G-protein-coupled receptors (GPCRs) to develop novel... | TECX competitors |
| Shattuck Labs Inc (STTK) | Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapies for the treatment of cancer and autoimmune diseases in the United States. | STTK competitors |
| Gyre Therapeutics Inc. (GYRE) | Gyre Therapeutics Inc. is a pioneering biopharmaceutical company at the forefront of developing advanced therapies for rare and complex diseases. | GYRE competitors |
Frequently Asked Questions About INDP
Who are Indaptus Therapeutics' main competitors?
The companies most similar to Indaptus Therapeutics include Avalo Therapeutics (AVTX), Candel Therapeutics (CADL), Century Therapeutics (IPSC), Surrozen (SRZN) and Kyverna Therapeutics, Inc. Common Stock (KYTX), listed from the closest match.
Who is Indaptus Therapeutics' biggest competitor?
OmniAb (OABI) is the largest of the similar companies at $716.17M; Avalo Therapeutics (AVTX) is the closest match by business profile, size, sector and industry.
How does INDP stock compare with its competitors?
INDP's net margin is 0.0% against a peer median of 0.0%.
Which of Indaptus Therapeutics' competitors pays a higher dividend?
Indaptus Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Indaptus Therapeutics bigger than its competitors?
No. Indaptus Therapeutics is 8th by market cap among the 13 companies on this page; the largest is OmniAb (OABI) at $716.17M.
INDP pages: Overview, Earnings, Forecast, Financials, Competitors